Quarterly report pursuant to Section 13 or 15(d)

Equity-Based Compensation (Tables)

v3.23.1
Equity-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Option Activity
A summary of stock options activity under the Plan as of March 31, 2023 and changes during three months ended March 31, 2023 is presented as follows:
Shares Weighted-Average Grant Date Fair Value per Share Weighted-Average Exercise Price per Share Weighted-Average Remaining Contractual Term (Years)
Outstanding at December 31, 2022
 2,153,591  $ 2.70  $ 7.22  8.60
Forfeited (37,999) 2.81  7.74 
Outstanding at March 31, 2023
 2,115,592  $ 2.70  $ 7.21  8.30
Schedule of Nonvested Restricted Stock Units Activity
A summary of restricted stock units activity under the Plan as of March 31, 2023 and changes during the three months ended March 31, 2023 is presented as follows:
Restricted Shares Weighted-Average Grant Date Fair Value per Share Weighted-Average Remaining Contractual Term (in Years) Aggregate Intrinsic Value
Unvested at December 31, 2022
 2,282,778  $ 6.30  1.3 $ 4,520 
Forfeited (96,944) 7.19 
Unvested at March 31, 2023
 2,185,834  $ 6.26  1.1 $ 6,623 
Schedule of Stock Compensation Expense
The table below presents the equity-based compensation expense recorded during the following periods:
Three Months Ended
March 31, 2023 March 31, 2022
Cost of Sales
Incentive Units $ —  $ 181 
Stock Options 46  12 
Restricted Stock Units 673  627 
Total cost of sales $ 719  $ 820 
Selling, general and administrative expenses
Incentive Units —  2,171 
Stock Options 361  409 
Restricted Stock Units 878  1,011 
Total selling, general and administrative expenses $ 1,239  $ 3,591 
Total equity-based compensation expense $ 1,958  $ 4,411